Literature DB >> 33239679

The lingering mysteries of metastatic recurrence in breast cancer.

Alessandra I Riggio1, Katherine E Varley1, Alana L Welm2.   

Abstract

Despite being the hallmark of cancer that is responsible for the highest number of deaths, very little is known about the biology of metastasis. Metastatic disease typically manifests after a protracted period of undetectable disease following surgery or systemic therapy, owing to relapse or recurrence. In the case of breast cancer, metastatic relapse can occur months to decades after initial diagnosis and treatment. In this review, we provide an overview of the known key factors that influence metastatic recurrence, with the goal of highlighting the critical unanswered questions that still need to be addressed to make a difference in the mortality of breast cancer patients.

Entities:  

Mesh:

Year:  2020        PMID: 33239679      PMCID: PMC7782773          DOI: 10.1038/s41416-020-01161-4

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  164 in total

Review 1.  CDK4/6 inhibitors in breast cancer therapy: Current practice and future opportunities.

Authors:  Filipa Lynce; Ayesha N Shajahan-Haq; Sandra M Swain
Journal:  Pharmacol Ther       Date:  2018-06-19       Impact factor: 12.310

2.  Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice.

Authors:  Jean Albrengues; Mario A Shields; David Ng; Chun Gwon Park; Alexandra Ambrico; Morgan E Poindexter; Priya Upadhyay; Dale L Uyeminami; Arnaud Pommier; Victoria Küttner; Emilis Bružas; Laura Maiorino; Carmelita Bautista; Ellese M Carmona; Phyllis A Gimotty; Douglas T Fearon; Kenneth Chang; Scott K Lyons; Kent E Pinkerton; Lloyd C Trotman; Michael S Goldberg; Johannes T-H Yeh; Mikala Egeblad
Journal:  Science       Date:  2018-09-28       Impact factor: 47.728

Review 3.  Advances in Endocrine-Based Therapies for Estrogen Receptor-Positive Metastatic Breast Cancer.

Authors:  Vassilis Aggelis; Stephen R D Johnston
Journal:  Drugs       Date:  2019-11       Impact factor: 9.546

4.  Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency.

Authors:  M D Cameron; E E Schmidt; N Kerkvliet; K V Nadkarni; V L Morris; A C Groom; A F Chambers; I C MacDonald
Journal:  Cancer Res       Date:  2000-05-01       Impact factor: 12.701

Review 5.  Breast cancer.

Authors:  Nadia Harbeck; Frédérique Penault-Llorca; Javier Cortes; Michael Gnant; Nehmat Houssami; Philip Poortmans; Kathryn Ruddy; Janice Tsang; Fatima Cardoso
Journal:  Nat Rev Dis Primers       Date:  2019-09-23       Impact factor: 52.329

6.  Circulating tumor cells, disease progression, and survival in metastatic breast cancer.

Authors:  Massimo Cristofanilli; G Thomas Budd; Matthew J Ellis; Alison Stopeck; Jeri Matera; M Craig Miller; James M Reuben; Gerald V Doyle; W Jeffrey Allard; Leon W M M Terstappen; Daniel F Hayes
Journal:  N Engl J Med       Date:  2004-08-19       Impact factor: 91.245

7.  Geographic Variation in Postoperative Imaging for Low-Risk Breast Cancer.

Authors:  Benjamin L Franc; Timothy P Copeland; Robert Thombley; Miran Park; Ben Marafino; Mitzi L Dean; W John Boscardin; Hope S Rugo; David Seidenwurm; Bhupinder Sharma; Stephen R Johnston; R Adams Dudley
Journal:  J Natl Compr Canc Netw       Date:  2018-07       Impact factor: 11.908

8.  A new description of cellular quiescence.

Authors:  Hilary A Coller; Liyun Sang; James M Roberts
Journal:  PLoS Biol       Date:  2006-03-07       Impact factor: 8.029

9.  Imaging tests in staging and surveillance of non-metastatic breast cancer: changes in routine clinical practice and cost implications.

Authors:  S De Placido; C De Angelis; M Giuliano; C Pizzi; R Ruocco; V Perrone; D Bruzzese; G Tommasielli; M De Laurentiis; S Cammarota; G Arpino; G Arpino
Journal:  Br J Cancer       Date:  2017-02-07       Impact factor: 7.640

10.  Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

Authors:  Nicola Aceto; Aditya Bardia; David T Miyamoto; Maria C Donaldson; Ben S Wittner; Joel A Spencer; Min Yu; Adam Pely; Amanda Engstrom; Huili Zhu; Brian W Brannigan; Ravi Kapur; Shannon L Stott; Toshi Shioda; Sridhar Ramaswamy; David T Ting; Charles P Lin; Mehmet Toner; Daniel A Haber; Shyamala Maheswaran
Journal:  Cell       Date:  2014-08-28       Impact factor: 41.582

View more
  47 in total

1.  MORC2/β-catenin signaling axis promotes proliferation and migration of breast cancer cells.

Authors:  Himanshu Singh Saroha; Rohith Kumar Guddeti; Jasmine P Jacob; Kiran Kumar Pulukuri; Prashanthi Karyala; Suresh B Pakala
Journal:  Med Oncol       Date:  2022-06-21       Impact factor: 3.064

2.  A candidate triple-negative breast cancer vaccine design by targeting clinically relevant cell surface markers: an integrated immuno and bio-informatics approach.

Authors:  Shashank Kumar; Mohd Shuaib; Kumari Sunita Prajapati; Atul Kumar Singh; Princy Choudhary; Sangeeta Singh; Sanjay Gupta
Journal:  3 Biotech       Date:  2022-02-20       Impact factor: 2.406

3.  Synergistic Effect of Quercetin Magnetite Nanoparticles and Targeted Radiotherapy in Treatment of Breast Cancer.

Authors:  Mostafa A Askar; Heba As El-Nashar; Mahmood A Al-Azzawi; Sahar S Abdel Rahman; Omama E Elshawi
Journal:  Breast Cancer (Auckl)       Date:  2022-03-25

Review 4.  Clinical and Biological Aspects of Disseminated Tumor Cells and Dormancy in Breast Cancer.

Authors:  Alexander Ring; Maria Spataro; Andreas Wicki; Nicola Aceto
Journal:  Front Cell Dev Biol       Date:  2022-06-28

5.  CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice.

Authors:  Anvar Soleimani; Farshad Mirzavi; Sara Nikoofal-Sahlabadi; Amin Reza Nikpoor; Bita Taghizadeh; Mehdi Barati; Mohammad Soukhtanloo; Mahmoud Reza Jaafari
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

6.  Local Suppression Effect of Paclitaxel-Impregnated Hydroxyapatite/Collagen on Breast Cancer Bone Metastasis in a Rat Model.

Authors:  Rempei Matsumoto; Toshitaka Yoshii; Satoru Egawa; Motonori Hashimoto; Takashi Hirai; Hiroyuki Inose; Yoto Oh; Koji Fujita; Atsushi Okawa; Shinichi Sotome
Journal:  Spine Surg Relat Res       Date:  2021-12-27

Review 7.  Metastasis prevention: targeting causes and roots.

Authors:  A A Schegoleva; A A Khozyainova; T S Gerashchenko; L D Zhuikova; Evgeny V Denisov
Journal:  Clin Exp Metastasis       Date:  2022-03-26       Impact factor: 4.510

8.  Targeting CLK4 inhibits the metastasis and progression of breast cancer by inactivating TGF-β pathway.

Authors:  Eunji Kang; Kanggeon Kim; Sook Young Jeon; Ji Gwang Jung; Hong-Kyu Kim; Han-Byoel Lee; Wonshik Han
Journal:  Cancer Gene Ther       Date:  2022-01-19       Impact factor: 5.854

Review 9.  The liver metastatic niche: modelling the extracellular matrix in metastasis.

Authors:  James Drew; Laura M Machesky
Journal:  Dis Model Mech       Date:  2021-04-15       Impact factor: 5.758

10.  Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma.

Authors:  Lixing Xiao; Guoying Zou; Rui Cheng; Pingping Wang; Kexin Ma; Huimin Cao; Wenyang Zhou; Xiyun Jin; Zhaochun Xu; Yan Huang; Xiaoyu Lin; Huan Nie; Qinghua Jiang
Journal:  BMC Cancer       Date:  2021-06-15       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.